Skip to content

Author

A. Cervantes-Arriaga

We have 2 of 139 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Huntington's disease in the era of somatic instability, biomarkers, and targeted therapies: A narrative review.

Genetic testing demonstrating an expanded HTT CAG repeat is the definitive diagnostic test and should be interpreted with genetic counseling and attention to allele categories, and therapeutic development.

A. Cervantes-Arriaga, Ashley Xanat Beltrán-Torres, Diego Romero-García et al. · 0 citations
Review Open access Jul 2026

Precision therapeutics and innovative clinical trial design in neurodegenerative diseases.

This review summarizes emerging therapeutic approaches, including monoclonal antibodies targeting protein aggregation, immune-modulating and metabolic interventions, antisense oligonucleotides, gene replacement and genome-editing strategies, stem cell-based therapies, and neurosurgical delivery platforms and neuromodulation technologies.

A. Domínguez-García, J. C. Delgado-Uriarte, A. Cervantes-Arriaga · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.